Entity

Time filter

Source Type

Golden Triangle, NC, United States

N/A

Grant
Agency: Department of Health and Human Services | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 0.00 | Year: 2001

N/A


N/A

Grant
Agency: Department of Health and Human Services | Branch: | Program: SBIR | Phase: Phase II | Award Amount: 49.99K | Year: 2001

N/A


Hardisty J.F.,Experimental Pathology Laboratories EPL | Willson G.A.,Experimental Pathology Laboratories EPL | McConnell E.E.,Toxpath Inc. | Frame S.R.,United Health Centers | And 3 more authors.
Drug and Chemical Toxicology | Year: 2010

Perfluorooctanoate (PFO) is a perfluorinated carboxylate that is widely distributed in the environment. A 2-year chronic study was conducted in rats fed either 30 or 300 ppm of ammonium perfluorooctanoate (APFO). To investigate the possible relationship of APFO exposure to proliferative mammary lesions, a Pathology Working Group (PWG) review of the original slides was performed. The consensus reached by the PWG was that the incidence of mammary-gland neoplasms was not affected by chronic dietary administration of APFO. Therefore, feeding female rats up to 300 ppm of APFO resulted in no increase in proliferative lesions of the mammary tissue. © 2010 Informa UK Ltd. Source

Discover hidden collaborations